These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8990820)

  • 41. Psychoactive drug treatment in retarded populations.
    Psychopharmacol Bull; 1982 Jan; 18(1):50-66. PubMed ID: 6124020
    [No Abstract]   [Full Text] [Related]  

  • 42. Risperidone-induced tardive dyskinesia.
    Saran BM
    J Clin Psychiatry; 1998 Jan; 59(1):29-30. PubMed ID: 9491064
    [No Abstract]   [Full Text] [Related]  

  • 43. The use of clozapine among individuals with intellectual disability: a review.
    Singh AN; Matson JL; Hill BD; Pella RD; Cooper CL; Adkins AD
    Res Dev Disabil; 2010; 31(6):1135-41. PubMed ID: 20692809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A crossover study of risperidone in children, adolescents and adults with mental retardation.
    Hellings JA; Zarcone JR; Reese RM; Valdovinos MG; Marquis JG; Fleming KK; Schroeder SR
    J Autism Dev Disord; 2006 Apr; 36(3):401-11. PubMed ID: 16596465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [When does the extrapyramidal syndrome become an adverse reaction to major psychotropic drugs? ].
    Csiky K
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1978; 23(2):131-4. PubMed ID: 30159
    [No Abstract]   [Full Text] [Related]  

  • 46. Meige's syndrome associated with risperidone therapy.
    Ananth J; Burgoyne K; Aquino S
    Am J Psychiatry; 2000 Jan; 157(1):149. PubMed ID: 10618045
    [No Abstract]   [Full Text] [Related]  

  • 47. Examining risperidone use in those diagnosed with autism 1 year after FDA approval.
    Valdovinos MG; Bailey L; Taylor SL
    J Clin Psychiatry; 2010 May; 71(5):651-2. PubMed ID: 20492856
    [No Abstract]   [Full Text] [Related]  

  • 48. Assessing the utility of atypical antipsychotic medication in adults with mild mental retardation and comorbid psychiatric disorders.
    Shedlack KJ; Hennen J; Magee C; Cheron DM
    J Clin Psychiatry; 2005 Jan; 66(1):52-62. PubMed ID: 15669889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arm tremor, tardive dyskinesia, and mental retardation.
    van Emmerik RE; Sprague RL; Newell KM
    Am J Ment Retard; 1993 Jul; 98(1):74-83. PubMed ID: 8103999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Weight gain with risperidone among patients with mental retardation: effect of calorie restriction.
    Cohen S; Glazewski R; Khan S; Khan A
    J Clin Psychiatry; 2001 Feb; 62(2):114-6. PubMed ID: 11247096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risperidone for aggression and self-injurious behavior in adults with mental retardation.
    Cohen SA; Ihrig K; Lott RS; Kerrick JM
    J Autism Dev Disord; 1998 Jun; 28(3):229-33. PubMed ID: 9656134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risperidone in anorexia nervosa.
    Newman-Toker J
    J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):941-2. PubMed ID: 10939220
    [No Abstract]   [Full Text] [Related]  

  • 53. The challenges of clinical psychopharmacological management.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 May; 50(5):17-20. PubMed ID: 22533844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health resource utilization and clinical outcomes with risperidone therapy in patients with serious mental illness.
    Sajatovic M; Ramirez LF; Belton J; McCormick R
    Compr Psychiatry; 1999; 40(3):198-202. PubMed ID: 10360614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychopathology and dyskinesia.
    Jeste DV; Barban L; Karson CN; Waldman IN; Patterson D; Anderson C; Wyatt RJ
    Psychopharmacol Bull; 1984; 20(1):41. PubMed ID: 6144135
    [No Abstract]   [Full Text] [Related]  

  • 56. Movement disorders in children with developmental disabilities taking risperidone.
    Demb HB; Nguyen KT
    J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):5-6. PubMed ID: 9893407
    [No Abstract]   [Full Text] [Related]  

  • 57. Side effect profiles of atypical antipsychotics, typical antipsychotics, or no psychotropic medications in persons with mental retardation.
    Advokat CD; Mayville EA; Matson JL
    Res Dev Disabil; 2000; 21(1):75-84. PubMed ID: 10750167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medication and physical activity and physical fitness in severe mental illness.
    Perez-Cruzado D; Cuesta-Vargas A; Vera-Garcia E; Mayoral-Cleries F
    Psychiatry Res; 2018 Sep; 267():19-24. PubMed ID: 29879601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of breast cancer in risperidone users: A nationwide cohort study.
    Reutfors J; Wingård L; Brandt L; Wang Y; Qiu H; Kieler H; Bahmanyar S
    Schizophr Res; 2017 Apr; 182():98-103. PubMed ID: 27823949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of patients with pulmonary tuberculosis and mental disorders].
    Rudoĭ NM; Chubakov TCh
    Probl Tuberk; 1996; (2):17-9. PubMed ID: 8657685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.